iohexol has been researched along with Cerebrovascular Moyamoya Disease in 2 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohno, T | 1 |
Kudo, K | 1 |
Zaharchuk, G | 1 |
Fujima, N | 1 |
Shirato, H | 1 |
Yang, CY | 1 |
Chen, YF | 1 |
Lee, CW | 1 |
Huang, A | 1 |
Shen, Y | 1 |
Wei, C | 1 |
Liu, HM | 1 |
2 other studies available for iohexol and Cerebrovascular Moyamoya Disease
Article | Year |
---|---|
Evaluation of diagnostic accuracy in CT perfusion analysis in moyamoya disease.
Topics: Adult; Aged; Blood Flow Velocity; Carotid Arteries; Cerebral Arteries; Cerebrovascular Circulation; | 2016 |
Multiphase CT angiography versus single-phase CT angiography: comparison of image quality and radiation dose.
Topics: Adult; Aged; Carotid Stenosis; Cerebral Angiography; Cerebral Arterial Diseases; Cerebral Infarction | 2008 |